Peptide Comparison · Recovery & Repair
These are the two most asked-about recovery peptides, and the internet treats them like interchangeable miracle shots. They are not. One is more localized, one more systemic, and they are often used together for exactly that reason. Here is the honest, provider-level comparison.
BPC-157 is a synthetic peptide based on a protective sequence found in gastric juice; it is associated with localized tissue repair, gut support, and the formation of new blood vessels at a site. TB-500 is related to thymosin beta-4 and is associated with broader, systemic effects on cell migration and tissue flexibility. The simplest framing: BPC-157 tends to act where you apply attention, TB-500 tends to act body-wide. Because those mechanisms complement each other, providers frequently pair them rather than choosing one.
| BPC-157 | TB-500 | |
|---|---|---|
| Origin | Synthetic; based on a gastric-juice peptide sequence | Related to thymosin beta-4 |
| Primary character | Localized repair | Systemic, body-wide |
| Associated with | Soft-tissue and tendon support, gut health, blood-vessel formation | Cell migration, tissue flexibility, broad recovery |
| Often used for | Targeted recovery, gut support | General recovery, mobility |
| Commonly combined? | Yes, frequently paired with TB-500 | Yes, frequently paired with BPC-157 |
| FDA approved? | No; 503A compounded, prescription only | No; 503A compounded, prescription only |
Educational only. No specific outcome is promised. Protocols, doses, and combinations are determined individually by your provider; Vesta does not publish medication prices.
BPC-157 and TB-500 are everywhere online, often labeled research use only with no prescription required. That label means they are not legal to sell for human use, and their purity, dosing, and sterility cannot be verified. At Vesta these are prescribed individually and dispensed through licensed 503A compounding pharmacies after a clinical evaluation. If a source skips the provider relationship, skip the source. Want a checklist for vetting any clinic? Here it is.
Both are studied for tissue repair and recovery, but they work differently. BPC-157 (a synthetic peptide based on a sequence found in gastric juice) is associated with localized healing, gut support, and blood-vessel formation. TB-500 (related to thymosin beta-4) is associated with broader, systemic effects on cell migration and flexibility. BPC-157 is often described as more localized, TB-500 as more systemic, which is why they are frequently paired.
Yes, and they commonly are. Their mechanisms are seen as complementary, BPC-157 more localized and TB-500 more systemic, so a combined protocol is a frequent approach. Whether a stack is appropriate, and at what dosing, is an individual clinical decision.
In a clinical wellness setting they are most often used to support recovery, soft-tissue and tendon health, and general repair. Outcomes and appropriateness vary by person; Vesta makes no guarantee of specific results and designs every protocol individually.
Neither is an FDA-approved drug product. At Vesta they are prescribed individually and dispensed through licensed 503A compounding pharmacies under a valid prescription after a clinical evaluation, which is the framework the practice operates within. Be cautious of research-use-only products sold online without a provider relationship.
Ali Claunch, NP-C, who holds SSRP certification (Seeds Scientific Research and Performance), designs and monitors every protocol, dispensed through licensed 503A pharmacies, available by telehealth across Utah, Arizona, and Idaho.
A $75 consultation with an SSRP certified provider, across Utah, Arizona, and Idaho.
Explore Peptide TherapyFor Utah, Arizona & Idaho patients. Unsubscribe any time.
Questions First?
Prefer to start with a conversation? Ali personally responds to every message within 24 hours.
Deciding between medications? Semaglutide vs tirzepatide, compared →
Meet one-on-one with Ali Claunch, NP-C through a HIPAA compliant telehealth consultation. We review your goals, health history, and labs, then build a personalized treatment plan. Caring for patients across Utah, Arizona, and Idaho, with in-clinic visits in Saratoga Springs.
Follow-up visits are included with an active membership. À la carte patients schedule a $75 follow-up consult at least every 90 days while on therapy.
Schedule a ConsultationA Note on Compounded Medications and FDA Oversight
Compounded peptides, GLP-1 medications, hormone therapies, NAD+ preparations, and other prescription items dispensed through Vesta Aesthetics are prepared by licensed 503A compounding pharmacies for individual patients pursuant to a valid prescription from Ali Claunch, NP-C, following a personalized clinical evaluation. Compounded medications are not FDA-approved. The FDA does not evaluate compounded preparations for safety, efficacy, or potency. Vesta Aesthetics operates in compliance with FDA regulations governing 503A patient-specific compounding and does not stock, resell, or distribute medications outside this framework. If the FDA changes guidance, restricts, or removes access to any compounded preparation, Vesta will discontinue that preparation in alignment with federal regulation.
Information on this site is educational and is not a substitute for individualized medical advice, diagnosis, or treatment. Outcomes vary by patient. No specific clinical result is promised or guaranteed. Use of any prescription medication carries risk; please review all risks with your provider before beginning therapy. Vesta Aesthetics is a self-pay medical practice and does not bill insurance. See our 503A Promise for full sourcing detail.